Asset Screening

At Evaluate, our mission is simple: to help patients gain access to life-saving therapies. Evaluate is a Norstella company, a collection of prominent pharmaceutical solutions providers that have joined forces to offer a full range of consultancy services and solutions. Evaluate provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. Our offerings include cutting-edge data solutions, consensus forecasts and expert advisory services alongside advanced technologies such as machine learning and predictive analytics.

The Asset Screening data product is a comprehensive dataset that provides a wide range of information related to drug development, clinical trials, and market analysis.

The following sets of data have been included in this listing:

Drugs - Historic Approvals & Launches (products): This table provides historical data on drug approvals and launches, which can be used to analyze trends and patterns in the pharmaceutical industry.

Drugs - Historic Approvals & Launches (indications): This table provides information on the indications for which drugs have been approved and launched.

Drugs - Names and Identifiers: This table contains names and identifiers of drugs, which can be used for cross-referencing with other datasets.

Drugs - Classifications: This table provides classification information for drugs, which can be useful for categorizing and analyzing drugs based on their classes.

Drugs - Product Sales: This table provides sales data for drugs, which can be used for market analysis.

Drugs - Profiles: This table provides detailed profiles of drugs, including their properties and uses.

Drugs - Patents: This table provides information on patents related to drugs, which can be useful for competitive analysis.

Drugs - Orphan drug designation: This table provides information on drugs that have been designated as orphan status.

Drugs - Events: This table provides information on significant events related to drugs, such as regulatory decisions or clinical trial results.

Drugs - Predicted approvals: This table provides predictions on future drug approvals, which can be used for forecasting and planning purposes.

Clinical trials - Trial costs: This table provides cost data for clinical trials, which can be used for budgeting and financial analysis.

Clinical trials - Dates: This table provides date information for clinical trials, which can be used for scheduling and timeline analysis.

Clinical trials - Outcomes: This table provides outcome data for clinical trials, which can be used for performance analysis and benchmarking.

Drug-Event-Profile: This table provides profiles of drug events, which can be used to understand the impact of specific events on drug development and marketing.

By analyzing this data, users can gain insights into drug development trends, market dynamics, competitive landscape, and more.

Once you subscribe to this listing, you will have access to all the data tables required.

Workflow:

• Consumer clicks Request button on Evaluate listing<br/>• Evaluate will reach out to the consumer and finalize terms.<br/>• Evaluate shares the data product with the consumer via Snowflake shares.

Additional Information<br/>This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.